BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36169254)

  • 1. BMS-202, a PD-1/PD-L1 inhibitor, decelerates the pro-fibrotic effects of fibroblasts derived from scar tissues via ERK and TGFβ1/Smad signaling pathways.
    Cai Y; Xiao M; Li X; Zhou S; Sun Y; Yu W; Zhao T
    Immun Inflamm Dis; 2022 Oct; 10(10):e693. PubMed ID: 36169254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
    Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
    Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP15 Enhances the Proliferation, Migration, and Collagen Deposition of Hypertrophic Scar-Derived Fibroblasts by Deubiquitinating TGF-βR1 In Vitro.
    Tu L; Lin Z; Huang Q; Liu D
    Plast Reconstr Surg; 2021 Nov; 148(5):1040-1051. PubMed ID: 34546211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.
    Li Y; Zhang W; Gao J; Liu J; Wang H; Li J; Yang X; He T; Guan H; Zheng Z; Han S; Dong M; Han J; Shi J; Hu D
    Stem Cell Res Ther; 2016 Aug; 7(1):102. PubMed ID: 27484727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad interacting protein 1 influences transforming growth factor-β
    Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
    J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
    Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
    Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
    Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
    Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
    [No Abstract]   [Full Text] [Related]  

  • 8. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
    Li Y; Yu Z; Zhao D; Han D
    Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
    Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
    Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
    Ying M; Chen Y; Yuan B
    Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts.
    Wang X; Qian Y; Jin R; Wo Y; Chen J; Wang C; Wang D
    PLoS One; 2013; 8(2):e55899. PubMed ID: 23418473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
    Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
    Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-9-5p inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting peroxisome proliferator-activated receptor β.
    Chai CY; Tai IC; Zhou R; Song J; Zhang C; Sun S
    Biol Open; 2020 Dec; 9(12):. PubMed ID: 33355167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts.
    Zeng J; Jiang B; Xiao X; Zhang R
    Mol Med Rep; 2020 Sep; 22(3):2573-2582. PubMed ID: 32705254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
    Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
    Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid inhibits human dermal fibroblasts hyperproliferation, migration, and collagen deposition induced by TGF-β via regulating the Smad2/3 pathway.
    Zhou X; Ye H; Wang X; Sun J; Tu J; Lv J
    Gene; 2023 May; 867():147367. PubMed ID: 36931410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor c-Maf drives macrophages to promote hypertrophic scar formation.
    Yang L; Song Y; Wang T; Cui Z; Wu J; Shi Y; Yu Z; Song B
    J Cosmet Dermatol; 2024 Feb; 23(2):639-647. PubMed ID: 37710417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.
    Fan C; Dong Y; Xie Y; Su Y; Zhang X; Leavesley D; Upton Z
    Int J Mol Med; 2015 Oct; 36(4):985-91. PubMed ID: 26239419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts.
    Wang X; Chu J; Wen CJ; Fu SB; Qian YL; Wo Y; Wang C; Wang DR
    Exp Cell Res; 2015 Mar; 332(2):202-11. PubMed ID: 25655281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑185 regulates transforming growth factor‑β1 and collagen‑1 in hypertrophic scar fibroblasts.
    Xiao K; Luo X; Wang X; Gao Z
    Mol Med Rep; 2017 Apr; 15(4):1489-1496. PubMed ID: 28259900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.